Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Z Potter

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Journal of Psychopharmacology (Oxford, England)|February 1, 2012
ECT treatment does not enhance neuroendocrine responses to serotonergic challengeH K Manji, J K Hsiao, E D Risby, et al.
The Journal of Clinical Psychiatry|June 1, 1991
Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levelsP E Keck, W P Carter, A A Nierenberg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 1, 1997
Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockadeM E Schmidt, J A Matochik, D S Goldstein, et al.
Archives of General Psychiatry|May 1, 1990
Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescentsM J Kruesi, J L Rapoport, S Hamburger, et al.
The American Journal of Psychiatry|December 1, 1985
Psychoses associated with bupropion treatmentR N Golden, S P James, M A Sherer, et al.
Archives of General Psychiatry|February 1, 1988
Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin outputR N Golden, S P Markey, E D Risby, et al.
Psychopharmacology|October 20, 1999
Cerebral glucose metabolic and plasma catecholamine responses to the alpha(2) adrenoceptor antagonist ethoxyidazoxan given to healthy volunteersM E Schmidt, R J Oshinsky, H G Kim, et al.
Psychopharmacology Bulletin|January 1, 1997
Acute alpha 2 blockade by idazoxan increases insulin and lowers plasma glucose during positron emission tomographyM E Schmidt, D S Goldstein, J L Schouten, et al.
Archives of General Psychiatry|June 1, 1991
The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjectsE D Risby, J K Hsiao, H K Manji, et al.
Archives of General Psychiatry|February 1, 1988
Bupropion in depression. II. The role of metabolites in clinical outcomeR N Golden, C L De Vane, S C Laizure, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Journal of Psychopharmacology (Oxford, England)|February 1, 2012
ECT treatment does not enhance neuroendocrine responses to serotonergic challengeH K Manji, J K Hsiao, E D Risby, et al.
The Journal of Clinical Psychiatry|June 1, 1991
Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levelsP E Keck, W P Carter, A A Nierenberg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 1, 1997
Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockadeM E Schmidt, J A Matochik, D S Goldstein, et al.
Archives of General Psychiatry|May 1, 1990
Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescentsM J Kruesi, J L Rapoport, S Hamburger, et al.
The American Journal of Psychiatry|December 1, 1985
Psychoses associated with bupropion treatmentR N Golden, S P James, M A Sherer, et al.
Archives of General Psychiatry|February 1, 1988
Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin outputR N Golden, S P Markey, E D Risby, et al.
Psychopharmacology|October 20, 1999
Cerebral glucose metabolic and plasma catecholamine responses to the alpha(2) adrenoceptor antagonist ethoxyidazoxan given to healthy volunteersM E Schmidt, R J Oshinsky, H G Kim, et al.
Psychopharmacology Bulletin|January 1, 1997
Acute alpha 2 blockade by idazoxan increases insulin and lowers plasma glucose during positron emission tomographyM E Schmidt, D S Goldstein, J L Schouten, et al.
Archives of General Psychiatry|June 1, 1991
The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjectsE D Risby, J K Hsiao, H K Manji, et al.
Archives of General Psychiatry|February 1, 1988
Bupropion in depression. II. The role of metabolites in clinical outcomeR N Golden, C L De Vane, S C Laizure, et al.
Pageof 17